- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04555876
Effect of High Tone External Muscle Stimulation on Peripheral Arterial Disease
High Tone External Muscle Stimulation On Endothelial Dysfunction And Walking Parameters In Peripheral Arterial Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The patients will randomly be divided into two equal groups in number:
Group A :
Thirty patients will participate in physical therapy program in form of high-tone external muscle stimulation (HTEMS), with Frequencies continuously will be scanned from 4096 Hz to 31768 Hz, allowing for a much higher power of up to 5000 mW to be introduced 3 times per week, for 10 weeks plus supervised regular aerobic exercise program on stationary bicycle with moderate intensity, ( score 12-14 on Borg scale for rate of perceived exertion) 40 minutes per session, 3 times per week, for 10 weeks .
- Group B:
Thirty patients will participate in a supervised regular aerobic exercise program only on stationary bicycle with moderate intensity, (score 12-14 on Borg scale for rate of perceived exertion) 40 minutes per session, 3 times per week, for 10 weeks.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1- Both genders are allowed to participate in the study. 2- The age range of patients will be from 50-60 years 3- All patients are diabetic from 5-7 years. 4- ABPI for all patients will be ranged from 0.65 to 0. 9 5- All patients are medically and psychologically stable. 6- Only ambulant patient without any aids will be selected 7- All patients are non smokers.
Exclusion Criteria:
- Patients with ABPI ( Ankle Brachial Pressure Index ≤ 0.4 )
- Patients who are unable to walk on treadmill or unable to attend sessions at the physical therapy department at Cairo university hospitals, 3 times a week.
- Patients with unstable cardiovascular conditions (those with a known history of recent myocardial infarction, uncontrolled hypertension, ischemic attacks, stroke, and congestive heart failure) will be excluded from this study.
- Patients with neurological problems that cause leg pain and polyneuropathy.
- Patients with active malignancy will be excluded from study
- Patients with ischemic ulcers or gangrenes
- Patients with a vascular surgical procedure or angioplasty within the previous year will be excluded from the study
Patients with musculoskeletal disorders (Diagnosed with severe osteoporosis, severe osteoarthritis or joint replacement).
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: high tone external muscle stimulation
- HiTop 191 appliance (gbo Medizintechnik AG, Rimbach, Germany) Device HiToP® 4 touch gbo Medizintechnik AG, this modern high-tech design with brushed aluminum surface and the 15" TFT LC D full color touch screen monitor offer to the health care professional an indispensable feature.
|
high-tone external muscle stimulation (HTEMS), with Frequencies continuously will be scanned from 4096 Hz to 31768 Hz, allowing for a much higher power of up to 5000 mW to be introduced 3 times per week, for 10 weeks
Other Names:
|
|
Experimental: stationary bicycle
supervised regular aerobic exercise program on stationary bicycle with moderate intensity, (score 12-14 on Borg scale for rate of perceived exertion) 40 minutes per session, 3 times per week, for 10 weeks.
|
high-tone external muscle stimulation (HTEMS), with Frequencies continuously will be scanned from 4096 Hz to 31768 Hz, allowing for a much higher power of up to 5000 mW to be introduced 3 times per week, for 10 weeks
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
measuring walking time in minutes
Time Frame: 10 weeks
|
maximum walking time the patient can walk in minutes without complain
|
10 weeks
|
|
measuring walking distance in meter
Time Frame: 10 weeks
|
maximum walking distance the patient can walk in meter
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measuring serum Nitric Oxide
Time Frame: 10 weeks
|
Three millimeter of venous blood will be drawn from the anticubital vein of each patient before conduction and after completion of the study.
Blood sample will be drawn for Nitric Oxide (NO) measurement.
|
10 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/002173
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Peripheral Neuropathy
-
Riphah International UniversityNot yet recruitingDiabetic Peripheral NeuropathyPakistan
-
Montiha AzeemRecruitingDiabetic Peripheral NeuropathyPakistan
-
Beni-Suef UniversityNot yet recruitingDiabetic Peripheral NeuropathyEgypt
-
Ain Shams UniversityRecruitingDiabetic Peripheral Neuropathy | Diabetic Neuropathy | Diabetic Peripheral Neuropathy in Type 2 Diabetic PatientsEgypt
-
University of FaisalabadActive, not recruitingDiabetic Peripheral NeuropathyPakistan
-
Lisa GriffinRecruitingHealthy Aging | Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy Type 2 | Diabetic Peripheral Neuropathy Type 2 - UncontrolledUnited States
-
Min LongRecruiting
-
Riphah International UniversityRecruitingDiabetic Peripheral Neuropathy (DPN)Pakistan
-
Pamlab, L.L.C.HealthCore, Inc.CompletedDiabetic Peripheral Neuropathy (DPN)United States
-
The First Affiliated Hospital of Zhejiang Chinese...The Third Affiliated hospital of Zhejiang Chinese Medical UniversityNot yet recruitingElectroacupuncture | Diabetic Peripheral Neuropathy (DPN)
Clinical Trials on high tone external muscle stimulation- stationary bicycle
-
Cairo UniversityNot yet recruiting
-
Paracelsus Medical UniversitySalzburger LandesklinikenCompletedPeripheral Nervous System ProblemAustria
-
Rosenblum, Jonathan I., DPMCompletedPeripheral Vascular DiseaseUnited States
-
Giresun UniversityCompletedUrinary Incontinence | Urinary Incontinence, Stress | Pelvic Floor Disorders | Electrical StimulationTurkey
-
VA Office of Research and DevelopmentUniversity of IowaCompleted
-
Cairo UniversityActive, not recruiting
-
Universidad Complutense de MadridActive, not recruitingFrailty | Electric Stimulation Therapy | WomenSpain
-
Lithuanian University of Health SciencesActive, not recruitingMeniscus Tear | Meniscus Injury | ACL Injuries | Arthroscopic Knee SurgeriesLithuania
-
Chang Gung Memorial HospitalCompletedProlonged Mechanical Ventilation | Protein DeficiencyTaiwan
-
Cairo UniversityCompletedOsteomyelitis Chronic | Bone DefectsEgypt